Thursday, November 12, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 30, 2025

TipRanks’ Perfect 10s: Unveiling 3 High-Scoring Stocks for 2026

View original at finance.yahoo.com
TipRanks’ Perfect 10s: Unveiling 3 High-Scoring Stocks for 2026 2026 is just a few days away, and that makes today a good time to start sorting out the best stocks for the new year…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Ouster is best-positioned fundamentally in the LiDAR industry, generating more revenue and better margins than its peers

    80% confidence
  • Pagaya stock has Buy rating with $39 price target

    80% confidence
  • Broad commercial adoption is the next major catalyst for quantum computing industry and D-Wave in particular

    80% confidence
  • D-Wave stock has Buy rating with $35 price target

    80% confidence
  • D-Wave is a compelling investment due to combination of large addressable market, real-world benefits from optimization across many industries, and expected energy efficiencies

    80% confidence
  • The elegance of Pagaya's two-sided network is starting to resonate across consumer lending ecosystem and with institutional investors, with much more to come

    80% confidence
  • Ouster stock has Overweight (Buy) rating with $33 price target

    80% confidence
  • Current period represents a good entry point for investors with >12-month horizon after recent underperformance

    80% confidence
  • Pagaya delivers more financial opportunity to more people, more often

    80% confidence
  • Ouster will continue to ramp up deployments to self-driving vehicles and autonomous delivery robots via partnerships with Serve Robotics and May Mobility

    80% confidence
  • D-Wave is a full-stack quantum company capable of delivering end-to-end solutions for science and business

    80% confidence
  • Pagaya sits near a real inflection point with more big lenders joining the platform, expanding monetization, improving loan portfolios, and diversifying lending sources

    80% confidence
  • Network volume is growing near 20% despite continued prudent underwriting standards

    80% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,565 source documents archived
Query this data → isubstrate.com
TipRanks’ Perfect 10s: Unveiling 3 High-Scoring Stocks for 2026 — Source | Via News | Via News